NO20005724L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005724L
NO20005724L NO20005724A NO20005724A NO20005724L NO 20005724 L NO20005724 L NO 20005724L NO 20005724 A NO20005724 A NO 20005724A NO 20005724 A NO20005724 A NO 20005724A NO 20005724 L NO20005724 L NO 20005724L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
NO20005724A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005724D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005724D0 publication Critical patent/NO20005724D0/no
Publication of NO20005724L publication Critical patent/NO20005724L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20005724A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000823 WO1999058108A1 (fr) 1998-05-14 1999-05-12 Composition biologiquement active

Publications (2)

Publication Number Publication Date
NO20005724D0 NO20005724D0 (no) 2000-11-13
NO20005724L true NO20005724L (no) 2001-01-09

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005724A NO20005724L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
US (1) US6537576B1 (fr)
EP (1) EP1082102B1 (fr)
JP (1) JP2002514587A (fr)
KR (1) KR100592971B1 (fr)
CN (1) CN1309553A (fr)
AT (1) ATE310500T1 (fr)
AU (1) AU736480B2 (fr)
CA (1) CA2331527C (fr)
DE (2) DE69928524T2 (fr)
ES (1) ES2155048T3 (fr)
GR (1) GR20010300013T1 (fr)
HU (1) HUP0102426A2 (fr)
IL (2) IL139576A0 (fr)
NO (1) NO20005724L (fr)
NZ (1) NZ508073A (fr)
PL (1) PL344051A1 (fr)
SE (1) SE9801704D0 (fr)
TR (1) TR200003589T2 (fr)
WO (1) WO1999058108A1 (fr)
ZA (1) ZA200006474B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (fr) * 2000-02-29 2001-09-07 Jie Zhang Timbre transdermique pour medicament ameliore
EP2457560A1 (fr) 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Compositions locales
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
AU2009302853B2 (en) 2008-10-06 2014-09-11 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． グリコピロレート塩
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
CN1309553A (zh) 2001-08-22
NO20005724D0 (no) 2000-11-13
ATE310500T1 (de) 2005-12-15
ZA200006474B (en) 2001-09-04
AU736480B2 (en) 2001-07-26
IL139576A0 (en) 2002-02-10
EP1082102A1 (fr) 2001-03-14
CA2331527A1 (fr) 1999-11-18
PL344051A1 (en) 2001-09-24
US6537576B1 (en) 2003-03-25
WO1999058108A1 (fr) 1999-11-18
DE1082102T1 (de) 2001-09-06
GR20010300013T1 (en) 2001-04-30
TR200003589T2 (tr) 2001-03-21
ES2155048T1 (es) 2001-05-01
EP1082102B1 (fr) 2005-11-23
HUP0102426A2 (hu) 2002-03-28
AU4405099A (en) 1999-11-29
ES2155048T3 (es) 2006-06-16
DE69928524T2 (de) 2006-08-10
CA2331527C (fr) 2010-04-13
KR20010052348A (ko) 2001-06-25
DE69928524D1 (de) 2005-12-29
KR100592971B1 (ko) 2006-06-23
NZ508073A (en) 2002-12-20
IL139576A (en) 2007-07-04
JP2002514587A (ja) 2002-05-21
SE9801704D0 (sv) 1998-05-14

Similar Documents

Publication Publication Date Title
Pommier et al. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei
Zhu et al. Electrochemical studies of quercetin interacting with DNA
BRPI0413432A (pt) método de esterificação de amido
van Iterson et al. A cytochemical localization of reductive sites in a Gram-negative bacterium: tellurite reduction in Proteus vulgaris
NO20005724L (no) Biologisk aktiv sammensetning
TR200200822T2 (tr) Uçucu bileşiklerin sıvı solüsyon içindeki katı maddelerden çıkarılması süreci
PT1224455E (pt) Processo de separacao de um composto quimico ou biologico numa mistura de compostos similares por difusao num meio tal como um gel
Qian et al. Free sulfurous acid (FSA) inhibition of biological thiosulfate reduction (BTR) in the sulfur cycle-driven wastewater treatment process
GB1503402A (en) Orally absorbable sterol glycoside
CA2048243A1 (fr) Les 4-amino-4,6-steroides et leur utilisation comme inhibiteurs de la 5-.alpha.-reductase
EP0331745A4 (en) Ferrocene derivatives, surfactants containing same, and process for producing thin organic film
NO20005725L (no) Biologisk aktiv sammensetning
TR200000442T2 (tr) Sıvı deterjan bileşimleri ve bunları hazırlamak için işlem.
Hansen A discussion of the paper “scanning electron micrographic studies of ettringite formation,” by PK Mehta★
Sun et al. Should releasing risk of sulfamethoxazole in bound-residual fraction of biochar-soil systems be neglected?
BR9915484A (pt) Processo para o isolamento contìnuo de proteìnas ativas
TW200506531A (en) Photoresist composition for deep uv and process thereof
JPS5315409A (en) Preparation for slow release of bioactive substance
JPS60243165A (ja) 一時的保護被膜及びその製造方法
Schaltegger et al. Dithranol: Further Investigations on the Structure-Activity-Relationship: The New Series of the 10-Mono-Alkyldithranol Derivatives
JPS52105282A (en) Immobilization of enzyme
KR890014025A (ko) 핵용출 화분의 제조방법
KR940002418A (ko) 액체 표백제 조성물
DE69928254D1 (de) Behandlung von zellen
BR0005589A (pt) Processo de reciclo de catalisadores homogêneos em sistemas lìquidos bifásicos contendo polìmero e solventes orgânicos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application